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Background: Visualization of the lesions in the lower genital tract is the mainstay for 
diagnosis of the four lesions found in female genital schistosomiasis (FGS), but colpo-
scopes are generally not available in low-resource settings.
Objective: We sought to review handheld devices that could potentially be used for 
FGS diagnosis.
Search strategy: We searched Medline and Embase 2015–2019 for handheld devices 
used in cervical cancer screening and FGS diagnosis.
Selection criteria: We excluded studies that did not compare the device to standard-
of-care colposcopes or histopathology.
Main results and conclusion: In 11 studies, four handheld colposcopes, two smart-
phones, and one compact digital camera were evaluated. Two handheld colposcopes 
were found to be potentially adequate for FGS diagnosis, namely Gynocular and Mobile 
ODT. The smartphones and digital camera did not have sufficient magnification to di-
agnose grainy sandy patches, one of the FGS lesion types. Customized software should 
be made to support the diagnosis of both FGS and cervical neoplasia. Real- time post-
graduate training and quality control should be considered in future studies of hand-
held colposcopes. For patients from schistosomiasis endemic areas, we recommend 
that handheld devices are used for FGS. Studies are needed to determine which of the 
two devices is most adequate for FGS diagnosis in schistosomiasis endemic areas.
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1  |  INTRODUC TION
Schistosomiasis is a disease caused by infection with a blood fluke 
parasite.1 It is endemic in 74 countries worldwide, mostly in low- and 
middle-income countries (LMICs). This neglected tropical disease af-
fects at least 261 million people in the world, and up to 569 million are 
at risk.1 The Schistosoma parasites reside in fresh water, and people are 
infected while bathing, washing, or performing agricultural work using 
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infested water bodies.1 Among parasitic infections, schistosomiasis is 
second only to malaria in terms of public health impact.2 The parasites 
penetrate the skin, lay eggs in the veins, and can affect many different 
organs. Female genital schistosomiasis (FGS) is caused by Schistosoma 
haematobium, which has a predilection for the urogenital tract.2 FGS is 
endemic in many African countries, and leads to significant suffering 
among women and girls.3,4 Small post mortem studies show that schis-
tosomiasis affects all parts of the female genital tract equally, but FGS 
is most commonly found on the cervix, probably because this is a tar-
get organ in cervical cancer screening.2,5 FGS causes abnormal vaginal 
discharge, bloody discharge, genital tumors, and ectopic pregnancies. 
It is associated with increased susceptibility to HIV and possibly also to 
HPV infection.2,6–8
Community-based studies have shown FGS prevalence ranging 
from 20% to 75% in areas where S. haematobium is endemic.2 Due 
to the range of symptoms, FGS is a differential diagnosis for many 
gynecologic conditions.9,10 Importantly, in LMICs, where syndromic 
diagnosis and point-of-care treatment are performed, FGS will con-
sistently be misdiagnosed and treated as cancer or as a sexually 
transmitted infection.9-12 Among healthcare professionals there is a 
need to raise the index of suspicion for FGS as a differential diagno-
sis to other reproductive tract ailments.13
The reference standard for diagnosis is a thorough inspection 
for lesions on the cervix, the fornices, and the vaginal walls with a 
colposcope.14 However, the use of a colposcope is not practical in re-
source-limited settings as it requires extensive training, continuous 
electricity, and is expensive to purchase, maintain, and use.15
In recent years, handheld, rechargeable, mobile, cheaper col-
poscopes have been developed for use in cervical cancer screen-
ing programs.16–20 Furthermore, it has been suggested that digital 
cameras and smartphones might be of dual use for FGS and cervical 
cancer screening.12,21 In countries where S. haematobium is endemic, 
screening for FGS could be incorporated into the cancer screening 
programs.12
Our aim was to systematically review studies of handheld cer-
vical cancer screening equipment that could potentially be used 
for point-of-care diagnosis of FGS, and to assess the quality of the 
evidence.
2  |  MATERIAL S AND METHODS
We first searched the Medline and Embase databases for research 
articles in the English language published between 2015 and 2019 
on diagnostic tools for FGS lesions using the key words: schistosom* 
AND (genital OR gynecological or gynAEcological) AND female AND 
(diagnostic OR diagnosis). This resulted in 60 articles as of January 
31, 2020. Each article was explored for the use of handheld devices 
in FGS diagnosis but none were found (Figure 1).
To further explore the literature for handheld devices we per-
formed a search on cervical cancer screening using the key words: 
(cervix uteri OR uterine cervical dysplasia OR cervical atypia OR cer-
vical precancer OR cervix) AND (colposcop* OR digital colposcop* 
OR smartphone* OR cervicograph* OR photo colposcop* OR cer-
vigram* OR computerized colposcop* OR magnifying OR light 
source OR Gynocular OR EVA System OR mobile ODT OR mobile 
colposcop* OR pocket colposcop* OR mobile health OR mHealth OR 
mobile medic* OR mMedic* OR equipment design) AND (developing 
countr* OR underdeveloped countr* OR low-resource countr* OR 
low-resource setting OR low-income countr* OR low and middle-in-
come countr* OR LMIC* OR point-of-care OR rural health OR rural 
health service* OR low cost) AND (screen* OR diagnos* OR visual* 
OR device OR apparat* OR techn*). This resulted in 74 articles as of 
January 31, 2020.
As shown in Figure 1 we excluded pilot studies that had resulted 
in larger studies, studies that reviewed unaided naked-eye inspec-
tions for lesions, and studies that did not compare the device to 
standard-of-care colposcopes or histopathology. We included arti-
cles that explored new devices for visual inspection of the cervix and 
were conducted in, or relevant for, low-resource settings. We added 
relevant articles found in the reference lists of the articles identi-
fied in the search and included 11 articles in total. It was beyond the 
scope of the study to explore devices that had not undergone peer 
review, current use of handheld devices in clinical practice, and the 
affordability of the devices in endemic areas.
F I G U R E  1  The search for articles. aReasons for exclusion: not 
about diagnostics. bReason for exclusion: duplicates
Handheld 
colposcopy                 
last 5 years
For female genital 
schistosomiasis n=0  
No relevant arcles 
found
For cervix cancer 
screening =74




reference lists = 4
Total = 11
Excludedb = 11
Excludeda = 56 
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Information was compiled according to the name of the handheld 
device/method. Information was gathered on the size and shape of 
the device, magnification, possibilities for vaginal wall inspection, 
focal distance, light type, seamless software for capture of images, 
seamless software for remote access, security, confidentiality, clas-
sification of morbidity, use of stationary colposcope for comparison, 
sensitivity, specificity, level of agreement, and Cohen's κ statistics.
We made assumptions that technologic development happens 
fast, older devices might be out of date, and that successful devices 
and methods developed before 2015 would likely have resulted in 
publications and dissemination into clinical practice. Some of the ar-
ticles were co-authored by the producers of the equipment, so there 
may be publication bias and selective reporting.
The summary measure used was a t test. Data were combined in 
Tables 1 and 2 for synthesis.
Issues of importance in the diagnosis of FGS are shown in 
Figure 2; there are four types of FGS lesions.10,14 The homogeneous 
yellow sandy patches are defined as sandy-looking areas with no vis-
ible grains when using the 15× magnification setting on the colpo-
scope.14 The grains of the sandy patches are approximately 0.05 mm 
by 0.2 mm long, are shaped as minuscule rice grains and they may 
be single or in clusters of up to 300 grains.9 Rubbery papules are 
firm, hard rubbery papulous lesions, which have only been seen in 
Madagascan women. These were observed by clinicians who have 
investigated women in five southern African countries, although one 
case was reported in Nigeria.9,22 Abnormal blood vessels are circu-
lar, convoluted, corkscrew, reticular, and/ or branched, and of un-
even-caliber in those with FGS.14 Figure 3 shows the range of steps 
explored in this manuscript.
3  |  RESULTS
None of the handheld devices in the 11 studies had been explored 
for FGS. All the reports evaluated the use of devices in the detec-
tion of precancerous and cancerous lesions on the cervix, using his-
topathology as the reference standard. The studies used abnormal 
cytology, symptoms, or HPV as inclusion criteria. Table 1 shows that 
we identified four different devices specifically developed for cervi-
cal cancer screening: the EVA System (MobileODT, 8 Ben Avigdor 
Street, Tel Aviv, Israel, handheld colposcope #1), the Gynocular 
(Järnbrotts Prästväg 2, Gothenburg, Sweden, handheld colposcope 
#2), the Magnivisualizer (National Institute of Cancer prevention and 
research, India, handheld colposcope #3), and the Pocket Colposcope 
(Duke Global Health Institute, North Carolina, handheld colposcope 
#4). The handheld colposcopes #1 and #2 have been approved by the 
US Food and Drug Administration. This was not stated for the hand-
held colposcopes #3 and #4, the digital camera and the smartphones.
For practicability, handheld devices have rechargeable batteries, 
and all provide magnification and a source of light. The handheld 
colposcope #4 is shaped like a tampon and is inserted into the va-
gina; it may be used without a speculum and can potentially be self- 
inserted. Infection prevention (from patient to device to patient) and 
disinfection procedures were not presented for any of the devices 
except for the handheld colposcope #4, which must be soaked in 
disinfectant for 25 minutes between patients.
All devices, except the handheld colposcope #4, must be used 
in conjunction with a speculum. The handheld colposcope #2 is a 
monocular, whereas the handheld colposcope #1 consists of a colpo-
scope body with a lens and an internal smartphone screen and soft-
ware to aid in the magnification. As shown in Figure 3(b) the devices 
must be agile and stable. The handheld colposcope #1 and 2 can be 
used with neck straps or on tripods, improving the stability. In the 
handheld colposcope #1 zooming and documenting lesions may be 
done without touching the device using the hand movement feature.
The handheld colposcope #1 had 16× magnification (on a cell 
phone screen), the handheld colposcope #2 had a maximum 12× 
magnification (in oculum), whereas the other mobile devices had 
lower maximum magnifications. The handheld colposcope #3 has a 
low magnification compared with the other colposcopes but is the 
only device that has a light spectrum equivalent to daylight. It lacks 
the possibility of taking digital images. The handheld colposcope #4 
has a focal distance of a few centimeters; however, it has a cross-po-
larized lens to minimize reflection. The handheld colposcopes #1 and 
2 emit high-intensity LED light. The handheld colposcope #1 also 
has a glare reduction mechanism. The green filter is only available in 
handheld colposcopes #1 and 2; this would be useful for the identi-
fication of the abnormal blood vessels found in FGS.
Considering the interpretation of the findings by the clinician 
using the device, to our knowledge, the handheld colposcope #1 has 
F I G U R E  2  Lesions found in female genital schistosomiasis. (a) Grainy sandy patches; (b) homogeneous yellow patch; (c) rubbery papules, 
firm, hard as rubber, to date only found in Madagascar; (d) abnormal blood vessels typical for female genital schistosomiasis; (e) severe lesion 
with contact bleeding. Photos: Dr. Elisabeth Kleppa, Dr. Bodo Raniandrasolo, and Dr. Eyrun F. Kjetland
(a) (b) (c) (d) (e)
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F I G U R E  3  Issues to be considered in colposcopy for female genital schistosomiasis. (a) Patient information should be handled ensuring 
confidentiality. Patient trust and comfort are prerogatives because the speculum cannot be turned for inspection of the anterior and 
posterior vaginal walls if the patient is tense.14 (b) It must be possible to tilt and change the height of the colposcope so that anterior surfaces 
of the vaginal “tunnel” can be inspected. It must be possible to change the distance between the colposcope and the patient to inspect from 
the innermost part of the vagina to the surface and vestibule.14 (c) The oculum or the screen must provide ample resolution, with minimum 
reflections, and the screen must be big enough for inspection if a smartphone is used. (d) Most rural nurses and clinicians have never been 
trained in identification of female genital schistosomiasis, and almost no nurses know colposcopy.10 (e) Therefore, the making of a diagnostic 
App that suggests a diagnosis should be considered.25 (f) Alternatively, transfer of high-quality, encrypted images could be done, bearing in 
mind that the clinic may never see the patient again if she leaves the clinic before her diagnosis. (g) Female genital schistosomiasis experts 
are not yet available in clinical practice. Health professionals need to undergo training and certification.12
not yet been compared with a stationary colposcope. None of the 
devices provided diagnostic decision support. The devices had not 
been explored in training scenarios, or tested in situations where 
several clinicians need to see the lesions simultaneously (Figure 3d). 
Table 2 shows comparable sensitivities for the handheld colposcopes 
with the smartphone and digital camera (t test, mean difference in 
sensitivity –1.9, 95% confidence interval –27.1 to 23.3, P = 0.90), and 
likewise with specificities (t test, mean difference 24.5, 95% CI –31.0 
to 80.1, P = 0.85).
None of the devices provided Applications (Apps) for automated 
lesion recognition (Figure 3e). However, all the devices except the 
handheld colposcope #3 could potentially be loaded with an App 
and an encryption feature.
Considering quality control, documentation, and training 
new clinicians, the handheld colposcopes #1 and 2 entail smart-
phone technology for image capturing and video documenta-
tion. All devices except the handheld colposcope #3 could be 
connected for transfer of documentation through wi-fi or with 
a USB plug, e.g. to a stationary computer with a larger screen 
or connection to an android phone. The handheld colposcope 
#1 has an image capturing platform for remote decision support 
and remote storage of documentation (Figure 3f). The patient 
review process encompasses the “Cloud” for image storage 
and sharing. However, the images and other information (such 
as clinical decisions) cannot yet be transferred seamlessly into 
other patient journal systems.
8  |    SØFTELAND ET AL.
4  |  DISCUSSION
The signs caused by S. haematobium infection in the lower female 
genital tract are focal, may be subtle, and can be easily missed.9,10 
FGS cannot be precluded without the systematic use of a colpo-
scope viewing the entire mucosal surface, including the vaginal wall 
and fornices. Rotating the speculum is necessary to view the pos-
terior and anterior vaginal walls. Therefore, the Pocket Colposcope 
cannot be used in the diagnosis of FGS. Further, the individual grains 
of the sandy patches seen in FGS are very small and previous studies 
indicate that the colposcope must provide a minimum of 15× magni-
fication.23 The device must be sufficiently stable to capture focused 
images and images must be of good resolution and color.21 The 
Magnivisualizer was the cheapest device but does not have satisfac-
tory magnification capabilities for FGS diagnosis. Furthermore, the 
Pocket Colposcope is used without a speculum and therefore vaginal 
discharge covering the surface, may obscure the visualization of the 
surface. Therefore, the Magnivisualizer and the Pocket Colposcope 
will not be discussed further.
The sandy patches are yellow in color. Therefore the require-
ments for a light source may be different from the requirements 
for diagnosing cervical intraepithelial neoplasia. Commercial 
torches (both LED and old-type light bulbs) have been found to be 
unsuitable for FGS diagnosis but the LED lights of the Gynocular 
and Mobile ODT have not been explored in FGS diagnosis.21 The 
abnormal blood vessels may be difficult to diagnose even with a 
high-quality stationary colposcope.24,25 A green filter, only avail-
able in the Mobile ODT and Gynocular, may aid in the identifi-
cation of the disease-specific abnormal blood vessels patterns of 
both cervical dysplasia and FGS.
The diagnostic accuracy of devices increases with the severity 
of cancerous lesions and this is probably be the same for FGS.10 The 
studies we reviewed show moderate results when it comes to sensi-
tivity and specificity for the detection of cervical intraepithelial neo-
plasia stage 2 or worse.26 FGS is typically endemic in rural areas, and 
in many such areas there is a lack of physicians.10 Nurses, midwives, 
and other health workers are already playing an important role in 
cervical cancer screening and there is a need to document the find-
ings for accountability purposes, quality control, and training.12,27,28 
However, nurses in nurse-driven primary healthcare clinics do not 
have training in colposcopy.10 Similarly, in non-endemic areas, in big 
cities, or in hospitals that serve immigrant populations, there will be 
a lack of exposure to FGS cases and lack of knowledge in those who 
have colposcopy skills.9
The possibility for telemedical evaluation may open a window 
of opportunity for screening.29 A prerogative for electronic trans-
fer of patient information is access to secure servers, so that only 
the intended recipient is able to access the images. The Mobile 
ODT can transfer images and this has been approved by the US 
Food and Drug Administration. The commercial camera technol-
ogy of cell phones may potentially provide an adequate substitute 
for colposcopes.30 However, encryption and password protection 
were not elaborated for most of the devices. If encrypted wi-fi or 
mobile data are available, then the Mobile ODT could potentially fa-
cilitate real-time and/or long-distance quality control and training. 
Furthermore, long-term storage, encryption, patient access, and 
transfer of information or images to clinicians who do not have the 
same system, must be resolved.
In endemic areas, inexperienced health professionals cannot 
seek advice on site due to the scarcity of experts. Remote consul-
tations through telemedicine will be challenging where access to 
internet might be unstable. Furthermore, telemedical service, that 
could serve all rural areas is a massive laborious undertaking. This 
would require training of image reviewers in each endemic country. 
We suggest that most of the routine diagnosis should therefore be 
done on site.27
Holmen et al have explored an automated colorimetric/texture 
image analysis for point of care FGS diagnosis.31 A cell phone or lap-
top application could support the diagnosis of FGS at the point of 
care and an App could potentially be incorporated into one of the 
handheld mobile colposcopes.31 Although automated image analysis 
has been explored for the identification of cervical dysplasia, none 
of the reported devices had been fitted with automated diagnostic 
tools.32 This feature has been explored for cervical cancer screen-
ing.33,34 Ideally, an App for automated image analysis at the point of 
care should have the possibility for both cervical dysplasia and FGS 
screening.25,35
There are limitations to these methods. The neck straps of 
the Gynocular and the Mobile ODT will leave the device hanging 
around the clinician's neck when not in use, this could be uncom-
fortable and there is a risk of contamination to and from the clini-
cian's clothes. Alternatively, placing the device on a tripod poses 
a separate range of problems, such as the cost of purchase, tri-
pod height might not be easy to adjust with one clean hand and 
it could get in the way of a rolling chair. None of the devices has 
been tested for detection of lesions on the vaginal wall, a nec-
essary feature in the diagnosis of FGS. Tilting the device for in-
spection of the vaginal wall would be possible with the Mobile 
ODT, the Gynocular, and smartphones. For the other devices, this 
is unclear. The studies presented different study designs; inter-
vention groups, control groups, and methods, and their diagnostic 
test results are not directly comparable. Ideally, experts in their 
field who have proven track records (compared with histology), 
should review the handheld devices while comparing with their 
own colposcope. Previous low-cost colposcopic methods, such 
as the AviScope, have shown limited usefulness because of the 
lack of digital image capture capability, fixed magnification, lim-
ited depth of focus, and poor illumination.19,36 Only Mobile ODTs 
EVA System portrayed how they would store images and transfer 
information. However, compatibility with digital patient journal 
systems was not discussed. Moreover, the costs for the reviewed 
devices is important, it might not be possible for nurses to pay 
at the current price level. The studies included here did not dis-
cuss essential issues such as cleansing between patients. We set 
our search to run from 4 years ago until present time because we 
assumed that successful devices and methods developed before 
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that time would have resulted in dissemination into clinical pub-
lications. We also made the assumption that technologic devel-
opment happens fast, and older devices might be out of date. 
This might not hold true. Publications from LMICs that are not in 
Medline/Embase might possibly be found in African or Asian local 
journals that are not listed in our search engines, these have not 
been explored. There might be studies that we did not reach in our 
search as the result of lack of access to recent publications, or new 
or unknown keywords.
Many African countries where schistosomiasis is endemic are 
using nurses as the stewards for primary healthcare diagnosis and 
treatments.28 Further research is necessary on improved point-
of-care diagnosis and support for point-of-care management.12 In 
conclusion, the diagnostic accuracy for FGS should be tested in 
both high-endemic and low-endemic populations, and screening 
must be useful and acceptable to women in endemic and non-en-
demic areas. We would suggest an integrated approach where the 
device and the App are adequate for diagnosis of both cervical 
dysplasia and FGS. Diagnostic imaging software used in other 
medical fields should be explored. Moreover, the reliability, use-
fulness, and training in the hands of the rural health professionals 
should be evaluated.
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